Pfizer and BioNTech Said They Started a Clinical Trial to Test a New Version of Their ... - Latest Tweet by Reuters

Pfizer and BioNTech said they started a clinical trial to test a new version of their vaccine specifically designed to target the COVID-19 Omicron variant, which has eluded some of the protection provided by the original two-dose vaccine regimen https://t.co/BRMkln47ub— Reuters (@Reuters) January 25, 2022

(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)